Monday, September 18, 2023 1:56:07 PM
All that notwithstanding, it's frustrating to have the financials outstanding at this juncture. BIEL's financials have been traditionally straightforward, and as someone pointed out previously, a good deal of the quarterly report is a cut and paste from the previous quarter. It's sales, profit/loss, and cash flow that are critical and it doesn't (or shouldn't) take much to put that together. We are not talking about a company with multiple subsidiaries or complicated accounting issues, at least historically, and there is nothing to indicate that has changed. It is tempting to conclude BIEL cannot afford to pay and external CPA to sign off, but I cannot imagine things are that bad in terms of cash flow. Then again, it is possible for even a profitable company to require a bankruptcy reorganization due to negative cash flows; though that seems counter-intuitive, it does happen, and BIEL is not a profitable operation.
Getting the fins out - regardless of what they show - would stop speculation and be a positive development. The longer they go unfiled, the more speculation it will drive, and the more negative that speculation will be.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM